HBV Mutation Detail Information

> Q215S Search Result


Mutation Information
Mutation Site Q215S
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug lamivudine (LAM)
Literature Information
PubMed PMID 16549970
Disease HBV-HIV coinfection
Published Year 2006
Journal AIDS (London, England)
Title Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
Author Matthews GV,Bartholomeusz A,Locarnini S,Ayres A,Sasaduesz J,Seaberg E,Cooper DA,Lewin S,Dore GJ,Thio CL
Evidence However, one patient who had received > 48 months of 3TC (71 months) had a mutation at rtQ215S, which is associated with ADV and 3TC resistance in vitro

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation